12:00 AM
 | 
Sep 13, 1999
 |  BC Week In Review  |  Clinical News  |  Regulatory

Menjugate conjugate vaccine against meningococcal C disease regulatory update

CHIR submitted an application for U.K. marketing approval for Menjugate....

Read the full 28 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >